The impact of a program for control of asthma in a low-income setting

World Allergy Organization Journal

Volumn 3, Issue 4, 2010, Pages 167-174

  Cruz, Alvaro A ^a   Souza Machado, Adelmir ^a   Franco, Rosana ^b   Souza Machado, Carolina ^a   Ponte, Eduardo V ^a   Santos, Pablo Moura ^a   Barreto, Maurício L ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b ProAR Hospital Especializado Octavio Mangabeira   (Brazil)

Author keywords

Asthma; Control; Hospitalization; Prevention; Treatment

Indexed keywords

ARTICLE; ASTHMA; BRAZIL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EL SALVADOR; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; LOWEST INCOME GROUP; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; SOCIAL STATUS; SOCIOECONOMICS; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION;

EID: 77954891093     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1097/WOX.0b013e3181dc3383     Document Type: Article

References (48)

1. Bousquet J, Bousquet PJ, Godard P, Daures JP. The public health implications of asthma. Bull World Heath Organ. 2005;83:548-554.
2. Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. World Health Organization, Geneva, 2007;146p.
3. Solé D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK; ISAAC-Brazilian Group. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC)- Phase 3. J Pediatr (Rio J). 2006;82:341-346. (Pubitemid 44526443)
4. Brasil, Ministério da Saúde. Informações de Saúde. Available at: http:// tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/ cnv/mruf.def]. Accessed October 20, 2008.
5. Brasil, Ministério da Saúde. Informações de Saúde. Available at: http:// tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/ cnv/obtuf.def]. Accessed October 23, 2008.
6. Neffen H, Fritscher C, Schacht FC, Levy G, Chiarella P, et al. Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey. Rev Panam Salud Publica. 2005;17:191-197.
7. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multi-country cross-sectional surveys. Lancet. 2006;368:733-743.
8. Mavale-Manuel S, Joaquim O, Macome C, Almeida L, Nunes E, et al. Asthma and allergies in schoolchildren of Maputo. Allergy. 2007;62: 265-271.
9. Barnes KC, Grant AV, Hansel NN, Gao P, Dunston GM. African Americans with asthma: genetic insights. Proc Am Thorac Soc. 2007; 4:58-68.
10. Martinez FD. Genes, environments, development and asthma: a reappraisal. Eur Respir J. 2007;29:179-184.
11. Nicolaou N, Siddique N, Custovic A. Allergic disease in urban and rural populations: increasing prevalence with increasing urbanization. Allergy. 2005;60:1357-1360.
12. US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Chapter 6. Respiratory Effects in Children from Exposure to Second-hand Smoke. Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
13. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy. 2008;63(Suppl)86:8-160.
14. Gotzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane database of systematic reviews (Online). 2004;CD001187.
15. de Vries MP, van den Bemt L, Aretz K, Thoonen BP, Muris JW, et al. House dust mite allergen avoidance and self-management in allergic patients with asthma: randomised controlled trial. Br J Gen Pract. 2007;57:184-190.
16. Luczynska C, Tredwell E, Smeeton N, Burney P. A randomized controlled trial of mite allergen-impermeable bed covers in adult mitesensitized asthmatics. Clin Exp Allergy. 2003;33:1648-1653.
17. Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, et al. Inner-City Asthma Study Group. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med. 2004; 351:1068-1080.
18. Wood LG, Garg ML, Powell H, Gibson PG. Lycopene-rich treatments modify noneosinophilic airway inflammation in asthma: proof of concept. Free Radic Res. 2008;42:94-102.
19. Basaran S, Guler-Uysal F, Ergen N, Seydaoglu G, Bingol-Karakoç G, Ufuk Altintas D. Effects of physical exercise on quality of life, exercise capacity and pulmonary function in children with asthma. J Rehabil Med. 2006;38:130-135.
20. Chaudhuri R, Livingston E, McMahon AD, Lafferty J, Fraser I, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med. 2006;174:127-133.
21. World Health Organization (WHO). Model List of Essential Medicines. Geneva, World Health Organization; 2007.
22. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332-336.
23. Bacharier LB, Raissy HH, Wilson L, McWilliams B, Strunk RC, Kelly HW. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Pediatrics. 2004;113:1693-1699.
24. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997;337: 1405-1411.
25. National Asthma Education and Prevention Program (NHLBI, NIH)- Expert Panel Report 3 (Publication No. 07-4051). Guidelines for the Diagnosis and Management of Asthma. Bethesda, US Department of Health and Human Services 2007;416p.
26. Global Strategy for Asthma Prevention and Management, full report. Global Initiative for Asthma (GINA); 2006;109pp.
27. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, et al. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006;61:663-670.
28. Evans R 3rd, Gergen PJ, Mitchell H, Kattan M, Kercsmar C, et al. A randomized clinical trial to reduce asthma morbidity among inner-city children: results of the National Cooperative Inner-City Asthma Study. J Pediatr. 1999;135:332-338. (Pubitemid 30180507)
29. Fischer GB, Camargos PA, Mocelin HT. The burden of asthma in children: a Latin American perspective. Paediatr Respir Rev. 2005;6: 8-13.
30. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA); 2002.
31. American Thoracic Society (ATS). Standardization of Spirometry. 1994 Update. Am J Respir Crit Care Med. 1995;152:1107-1136.
32. Pereira CAC, Barreto SP, Simões JG, Pereira FWL, Gerstler JG, Nakatani J. Valores de Referência para Espirometria em uma amostra da população brasileira adulta. J Bras Pneumol. 1992;18:10-12.
33. Okie S. Fighting HIV: lessons from Brazil. N Engl J Med. 2006;54:191-197.
34. Juniper EF, Guyatt GH, Epstein RS. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47:76-83.
35. Leite M, Ponte EV, Petroni J, D'Oliveira A Jr, Pizzichini E, Cruz AA. Evaluation of the Asthma Control Questionnaire validated for use in Brazil. J Bras Pneumol. 2008;34:756-763.
36. Universidade Federal da Bahia, Instituto de Saúde Coletiva. Programa de Economia da Saúde. Available at: http://www.pecs.ufba.br/ scripts/ arquivos/default.asp]. Accessed November 9, 2008.
37. Eddy D. Cost-effectiveness analysis: a conversation with my father JAMA. 1992;267:1669-1675.
38. Drummond M, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation. In: Methods for the Economic Evaluation. London: Oxford University; 1997.
39. Ponte E, Franco RA, Souza-Machado A, Souza-Machado C, Cruz AA. Impact that a program to control severe asthma has on the use of Unified Health System resources in Brazil. J Bras Pneumol. 2007; 33:15-19.
40. Franco R, Nascimento HF, Cruz AA, Santos AC, Souza-Machado C, et al. The economic impact of severe asthma to low-income families. Allergy. 2009;64:478-483.
41. Souza-Machado C, Souza-Machado A, Franco R, Ponte EV, Barreto ML, et al. Rapid reduction in hospitalizations after an intervention to manage severe asthma. Eur Respir J. 2010;35:1-7.
42. Franco R, Santos AC, do Nascimento HF, Souza-Machado C, Ponte E, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007;7:82.
43. Ponte EV, Franco R, Nascimento HF, Souza-Machado A, Cunha S, et al. Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis. Allergy. 2008;63:564-569.
44. Kocevar VS, Thomas J, Jonsson L, Yin DD, Bisgaard H. Association between allergic rhinitis and hospital resource use among asthmatic children in Norway. Allergy. 2005;60:338-342.
45. Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthma related heath resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics. 2005;115:129-134.
46. Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of allergic rhinitis on astma-related heath care use by adults. Clin Exp Allergy. 2005;35:282-287.
47. Cruz AA. The united airways require an holistic approach to management. Allergy. 2005;60:871-874.
48. Cruz AA, Bousquet PJ. The unbearable cost of severe asthma in underprivileged populations. Allergy. 2009;64:319-321.